Inhibition of 5-hydroxytryptamine reuptake by amitryptyline an zimelidine and its relationship to their therapeutic action.
Amitriptyline and zimelidine significantly reduce the uptake of 5-HT into the blood platelets of depressive patients. The degree of inhibition is significantly correlated with the plasma drug level of amitriptyline. No significant relationship could be detected between the degree of inhibition of uptake and therapeutic outcome. The accepted mode of action of tricyclic antidepressant drugs and the deficiency hypotheses of affective disorders are discussed.
D000499:Allylamine / Q000031:analogs & derivatives / Q000494:pharmacology / Q000627:therapeutic use; D000639:Amitriptyline / Q000097:blood / Q000494:pharmacology* / Q000627:therapeutic use; D000928:Antidepressive Agents / Q000494:pharmacology* / Q000627:therapeutic use; D001792:Blood Platelets / Q000378:metabolism; D002986:Clinical Trials as Topic; D003863:Depression / Q000188:drug therapy; D005260:Female; D006801:Humans; D007700:Kinetics; D008297:Male; D011569:Psychiatric Status Rating Scales; D011725:Pyridines / Q000494:pharmacology* / Q000627:therapeutic use; D012701:Serotonin / Q000097:blood / Q000378:metabolism*
D000928:Antidepressive Agents; D011725:Pyridines; D000639:Amitriptyline; D012701:Serotonin; D000499:Allylamine